Integration Sessions
EMBARK Psychedelic Therapy for Depression April 23, 2024 DOI: 10.1093/9780197762622.003.0008 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Proposes that the EMBARK model's participant-centric integration process, involving a three-step approach and three spheres of integration including social change, can effectively weave insights from psychedelic therapy into daily life. |
Abstract
AbstractChapter 7 underscores the pivotal role of integration sessions in psychedelic therapy, where insights from medicine sessions are woven into the fabric of daily life. It presents the EMBARK model’s flexible, participant-centric approach to integration, focusing adaptively on the clinical domains that emerged for the participant. It provides guidelines and goals for the practitioner in selecting the most relevant goals for each participant within the six clinical domains. The chapter outlines a three-step process for integration: listening to understand the participant’s experience, setting actionable goals in the form of new attitudes and behaviors, and enacting these changes. It introduces the concept of three spheres of integration, including the innovative idea of participating in social change as a therapeutic growth avenue. The chapter also provides guidance on handling disappointing medicine session experiences, responding to challenging events, and managing serious adverse outcomes.
Citations in the library
Cites 217
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
and 212 more in the library